Product analysis summary: device returned for evaluation.
Two dislodged stents returned for analysis, 2.
25 x 30 resolute onyx (pli 10) and 2.
25 x 38mm resolute onyx (pli 20).
Extensive deformation was evident to stents with struts severely stretched.
Fracture points were evident to the stent wires.
It was not possible to identify pli 10 or 20 due to the deformation.
If information is provided in the future, a supplemental report will be issued.
|
A 2.
25 x 30 resolute onyx rx coronary, drug eluting stent (pli10) was used to treat a severely calcified, mildly tortuosity lesion exhibiting 80% stenosis in the proximal right coronary artery (rca).
There was no issues removing the device from the hoop.
The device was inspected with no issues.
The lesion was pre dilated.
The device did not pass through a previously deployed stent.
Resistance was encountered.
Excessive force was not used.
An attempt was then made to deliver a 2.
25 x 38 mm resolute onyx rx coronary, drug eluting stent (pli20) through a proximal 2.
25 x 30 resolute onyx rx coronary, drug eluting stent (pli10) to a distal lesion the stent could not pass the proximal stent.
There was no damage noted to the packaging of the 2.
25 x 38mm device (pli20).
The 2.
25 x 38mm device was inspected with no issues, negative prep was not performed.
It was reported that the 2.
25 x 38 resolute stent (pli 20) deformed inside the 2.
25 x 30 resolute onyx rx stent (pli 10).
During removal of the 2.
25 x 38mm deformed stent (pli20) it caught on the 2.
25 x 30mm stent (pli10) and the 2.
25 x 30mm stent (pli10) dislodged.
Both stents were snared in the aorta and removed.
The lesion was then treated with a 2.
0 x 22 and 2.
25 x 38 resolute onyx rx coronary, drug eluting stent.
The patient is alive with no injury.
|